Insider Transactions Reported | Halozyme Therapeutics(HALO)saw insider trading activity on 7/10/2025

Halozyme Therapeutics(HALO) saw insider trading activity on 7/10/2025, there were 9 insider trades during the day.

【History Insider Transaction】

Declare date	Position	Name	Buy/Sell	Quantity	Price per share/USD	Total Amount/USD
7/10/2025	PRESIDENT AND CEO	Torley Helen	Sell	4254	56.74	241.38k
7/10/2025	PRESIDENT AND CEO	Torley Helen	Sell	16402	55.74	914.21k
7/10/2025	PRESIDENT AND CEO	Torley Helen	Sell	19792	56.43	1116.78k
7/10/2025	PRESIDENT AND CEO	Torley Helen	Sell	3598	54.48	196.03k
7/10/2025	PRESIDENT AND CEO	Torley Helen	Sell	208	57.08	11.87k
7/10/2025	PRESIDENT AND CEO	Torley Helen	Sell	15746	57.62	907.24k
7/10/2025	PRESIDENT AND CEO	Torley Helen	Buy	60000	8.11	486.6k
6/24/2025	PRESIDENT AND CEO	Torley Helen	Sell	20000	52.96	1059.2k
6/24/2025	PRESIDENT AND CEO	Torley Helen	Sell	20000	52.57	1051.46k
6/24/2025	PRESIDENT AND CEO	Torley Helen	Sell	4489	53.11	238.41k

[Company Profile]
Halozyme Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. The company's research targets the extracellular matrix, an area outside the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, the company has developed unique scientific expertise that allows it to pursue this target-rich environment for the development of future therapies. The company was founded in 1998 and reincorporated from the State of Nevada to the State of Delaware in November 2007.